Ingenia Therapeutics Inc. — Form D
Ingenia Therapeutics Inc. of WATERTOWN, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-11-30. The offering totals $16.0M, of which $7.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-11-30
- Form: D
- Accession: 0001796831-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $16.0M
- Amount sold: $7.0M
- Remaining: $9.0M
- Investors: 5
- Date of first sale: 2022-11-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-466183
Issuer
- Name: Ingenia Therapeutics Inc.
- CIK: 0001796831
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 134 COOLIDGE AVENUE, WATERTOWN, MA, 02472
- Phone: (781) 491-9005
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Sung Jae Kim | Director | Watertown, MA |
| Heewon Park | Director | Watertown, MA |
| Sang Gyun Kim | Director | Watertown, MA |
| Eric Furfine | Director | Watertown, MA |
| Joo Hee Kwak | Director | Watertown, MA |
| Sangyeul Han | Director | Watertown, MA |
| Sangyeul Han | Executive Officer | Watertown, MA |
| Kwang Ho Cheong | Director | Watertown, MA |
| Minji Kim | Director | CAMBRIDGE, MA |
| Minji Kim | Executive Officer | CAMBRIDGE, MA |
Other filings by this issuer (3)
More